| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.768 | 0.004 | 0.768 | 5 Hydroxytryptamine release inhibitor | 0.608 0.01 DBMET00686 | ||
| 0.676 | 0.01 | 0.676 | Cholesterol antagonist | 0.653 0.012 DBMET00686 | ||
| 0.676 | 0.035 | 0.676 | Antiinflammatory | 0.636 0.044 DBMET00686 | ||
| 0.612 | 0.034 | 0.612 | Caspase 9 stimulant | 0.477 0.069 DBMET00686 | ||
| 0.587 | 0.011 | 0.587 | Histamine release inhibitor | 0.532 0.02 DBMET00686 | ||
| 0.604 | 0.031 | 0.604 | Transcription factor NF kappa B inhibitor | 0.544 0.038 DBMET00686 | ||
| 0.583 | 0.03 | 0.627 | Cyclophilin D inhibitor | 0.627 0.023 DBMET00686 | DBMET00686 | |
| 0.502 | 0.007 | 0.502 | Non-steroidal antiinflammatory agent | 0.368 0.017 DBMET00686 | ||
| 0.481 | 0.006 | 0.557 | Alpha-N-acetylglucosaminidase inhibitor | 0.557 0.004 DBMET00686 | DBMET00686 | |
| 0.46 | 0.009 | 0.462 | Calcium channel activator | 0.462 0.009 DBMET00686 | DBMET00686 | |
| 0.495 | 0.051 | 0.495 | Analgesic | 0.472 0.058 DBMET00686 | ||
| 0.455 | 0.017 | 0.455 | Hypolipemic | 0.411 0.023 DBMET00686 | ||
| 0.469 | 0.034 | 0.469 | Antithrombotic | 0.307 0.083 DBMET00686 | ||
| 0.424 | 0.005 | 0.424 | Neurotrophic factor enhancer | 0.388 0.006 DBMET00686 | ||
| 0.44 | 0.029 | 0.44 | Apoptosis antagonist | 0.39 0.041 DBMET00686 | ||
| 0.432 | 0.035 | 0.432 | Caspase 3 stimulant | 0.397 0.046 DBMET00686 | ||
| 0.439 | 0.044 | 0.439 | Vasodilator, peripheral | 0.306 0.094 DBMET00686 | ||
| 0.43 | 0.04 | 0.43 | 5 Hydroxytryptamine release stimulant | 0.387 0.048 DBMET00686 | ||
| 0.465 | 0.085 | 0.465 | Apoptosis agonist | 0.376 0.125 DBMET00686 | ||
| 0.387 | 0.007 | 0.387 | Insulin sensitizer | 0.323 0.012 DBMET00686 | ||
| 0.444 | 0.065 | 0.495 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.495 0.036 DBMET00686 | DBMET00686 | |
| 0.438 | 0.061 | 0.459 | Antibacterial | 0.459 0.054 DBMET00686 | DBMET00686 | |
| 0.393 | 0.02 | 0.395 | Transcription factor STAT3 inhibitor | 0.395 0.019 DBMET00686 | DBMET00686 | |
| 0.381 | 0.009 | 0.381 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.349 0.013 DBMET00686 | ||
| 0.375 | 0.025 | 0.393 | Transcription factor STAT inhibitor | 0.393 0.02 DBMET00686 | DBMET00686 | |
| 0.418 | 0.069 | 0.497 | Calcium channel L-type activator | 0.497 0.029 DBMET00686 | DBMET00686 | |
| 0.361 | 0.012 | 0.361 | Lipocortins synthesis antagonist | 0.309 0.019 DBMET00686 | ||
| 0.346 | 0.004 | 0.346 | Keratolytic | 0.291 0.004 DBMET00686 | ||
| 0.35 | 0.008 | 0.35 | Phospholipase A2 inhibitor | 0.309 0.012 DBMET00686 | ||
| 0.402 | 0.062 | 0.402 | Immunosuppressant | 0.268 0.136 DBMET00686 | ||
| 0.371 | 0.032 | 0.629 | Superoxide dismutase inhibitor | 0.629 0.005 DBMET00686 | DBMET00686 | |
| 0.363 | 0.026 | 0.363 | Interleukin agonist | 0.286 0.055 DBMET00686 | ||
| 0.347 | 0.024 | 0.361 | Anesthetic general | 0.361 0.022 DBMET00686 | DBMET00686 | |
| 0.356 | 0.036 | 0.38 | Sodium/bile acid cotransporter inhibitor | 0.38 0.024 DBMET00686 | DBMET00686 | |
| 0.356 | 0.036 | 0.356 | Hypoglycemic | 0.318 0.047 DBMET00686 | ||
| 0.332 | 0.013 | 0.332 | Protein kinase stimulant | 0.257 0.025 DBMET00686 | ||
| 0.326 | 0.015 | 0.441 | Protein-tyrosine phosphatase inhibitor | 0.441 0.006 DBMET00686 | DBMET00686 | |
| 0.31 | 0.005 | 0.343 | Alcohol dehydrogenase inhibitor | 0.343 0.004 DBMET00686 | DBMET00686 | |
| 0.313 | 0.008 | 0.313 | Expectorant | 0.225 0.016 DBMET00686 | ||
| 0.311 | 0.008 | 0.37 | Interleukin 4 antagonist | 0.37 0.005 DBMET00686 | DBMET00686 | |
| 0.307 | 0.005 | 0.407 | Potassium channel (Ca-activated) activator | 0.407 0.004 DBMET00686 | DBMET00686 | |
| 0.319 | 0.017 | 0.319 | Interferon gamma antagonist | 0.311 0.018 DBMET00686 | ||
| 0.303 | 0.005 | 0.369 | Uric acid excretion stimulant | 0.369 0.004 DBMET00686 | DBMET00686 | |
| 0.337 | 0.042 | 0.431 | Antiamyloidogenic | 0.431 0.024 DBMET00686 | DBMET00686 | |
| 0.295 | 0.005 | 0.4 | AMP-activated protein kinase stimulant | 0.4 0.004 DBMET00686 | DBMET00686 | |
| 0.304 | 0.017 | 0.308 | Monophenol monooxygenase inhibitor | 0.308 0.017 DBMET00686 | DBMET00686 | |
| 0.29 | 0.008 | 0.31 | Ferrochelatase inhibitor | 0.31 0.007 DBMET00686 | DBMET00686 | |
| 0.326 | 0.045 | 0.394 | Free radical scavenger | 0.394 0.03 DBMET00686 | DBMET00686 | |
| 0.286 | 0.005 | 0.323 | Macrophage migration inhibitory factor inhibitor | 0.323 0.004 DBMET00686 | DBMET00686 | |
| 0.29 | 0.011 | 0.363 | UDP-glucose 4-epimerase inhibitor | 0.363 0.007 DBMET00686 | DBMET00686 | |
| 0.339 | 0.061 | 0.339 | Vasodilator, coronary | 0.266 0.119 DBMET00686 | ||
| 0.282 | 0.005 | 0.282 | Mucolytic | 0.219 0.01 DBMET00686 | ||
| 0.333 | 0.056 | 0.333 | Lipoxygenase inhibitor | 0.322 0.061 DBMET00686 | ||
| 0.315 | 0.038 | 0.454 | 5 Hydroxytryptamine uptake stimulant | 0.454 0.007 DBMET00686 | DBMET00686 | |
| 0.28 | 0.004 | 0.336 | Electrolyte absorption antagonist | 0.336 0.004 DBMET00686 | DBMET00686 | |
| 0.327 | 0.06 | 0.588 | Aldehyde oxidase inhibitor | 0.588 0.021 DBMET00686 | DBMET00686 | |
| 0.271 | 0.007 | 0.271 | Cyclooxygenase 3 inhibitor | 0.166 0.036 DBMET00686 | ||
| 0.276 | 0.015 | 0.351 | Succinate dehydrogenase inhibitor | 0.351 0.005 DBMET00686 | DBMET00686 | |
| 0.261 | 0.005 | 0.42 | Potassium channel large-conductance Ca-activated activator | 0.42 0.004 DBMET00686 | DBMET00686 | |
| 0.26 | 0.005 | 0.26 | ABCA1 expression enhancer | 0.193 0.01 DBMET00686 | ||
| 0.266 | 0.012 | 0.457 | GABA C receptor agonist | 0.457 0.004 DBMET00686 | DBMET00686 | |
| 0.273 | 0.02 | 0.273 | Nitric-oxide synthase stimulant | 0.223 0.057 DBMET00686 | ||
| 0.252 | 0.004 | 0.252 | Sphingosine 1-phosphate receptor 5 antagonist | 0.228 0.005 DBMET00686 | ||
| 0.289 | 0.041 | 0.289 | Gastrin inhibitor | 0.227 0.109 DBMET00686 | ||
| 0.25 | 0.007 | 0.263 | Triose-phosphate isomerase inhibitor | 0.263 0.006 DBMET00686 | DBMET00686 | |
| 0.251 | 0.008 | 0.59 | Porphobilinogen synthase inhibitor | 0.59 0.003 DBMET00686 | DBMET00686 | |
| 0.258 | 0.015 | 0.346 | Protein-tyrosine phosphatase 1B inhibitor | 0.346 0.008 DBMET00686 | DBMET00686 | |
| 0.289 | 0.046 | 0.289 | Cyclic AMP phosphodiesterase inhibitor | 0.277 0.051 DBMET00686 | ||
| 0.282 | 0.04 | 0.282 | Platelet adhesion inhibitor | 0.173 0.086 DBMET00686 | ||
| 0.246 | 0.005 | 0.378 | Alcohol oxidase inhibitor | 0.378 0.004 DBMET00686 | DBMET00686 | |
| 0.285 | 0.049 | 0.307 | DNA synthesis inhibitor | 0.307 0.041 DBMET00686 | DBMET00686 | |
| 0.247 | 0.012 | 0.269 | Xanthine oxidase inhibitor | 0.269 0.01 DBMET00686 | DBMET00686 | |
| 0.279 | 0.045 | 0.314 | Tyrosine 3 hydroxylase inhibitor | 0.314 0.027 DBMET00686 | DBMET00686 | |
| 0.263 | 0.028 | 0.291 | Amyloid beta precursor protein antagonist | 0.291 0.019 DBMET00686 | DBMET00686 | |
| 0.251 | 0.018 | 0.251 | Cholesterol synthesis inhibitor | 0.228 0.021 DBMET00686 | ||
| 0.296 | 0.063 | 0.358 | Antioxidant | 0.358 0.044 DBMET00686 | DBMET00686 | |
| 0.253 | 0.02 | 0.253 | Cyclooxygenase 1 inhibitor | 0.233 0.025 DBMET00686 | ||
| 0.251 | 0.019 | 0.275 | Adenylate cyclase inhibitor | 0.275 0.016 DBMET00686 | DBMET00686 | |
| 0.235 | 0.005 | 0.311 | Glutamate decarboxylase inhibitor | 0.311 0.003 DBMET00686 | DBMET00686 | |
| 0.292 | 0.063 | 0.292 | Aryl hydrocarbon receptor agonist | 0.278 0.068 DBMET00686 | ||
| 0.246 | 0.02 | 0.246 | Insulin secretagoues | 0.229 0.024 DBMET00686 | ||
| 0.231 | 0.008 | 0.32 | HIV-1 integrase (3'-Processing) inhibitor | 0.32 0.005 DBMET00686 | DBMET00686 | |
| 0.223 | 0.002 | 0.223 | Ca2+-transporting ATPase inhibitor | 0.216 0.003 DBMET00686 | ||
| 0.228 | 0.008 | 0.272 | HIV-1 integrase (Strand Transfer) inhibitor | 0.272 0.005 DBMET00686 | DBMET00686 | |
| 0.229 | 0.012 | 0.229 | Arachidonic acid antagonist | 0.219 0.018 DBMET00686 | ||
| 0.261 | 0.044 | 0.3 | RNA-directed DNA polymerase inhibitor | 0.3 0.032 DBMET00686 | DBMET00686 | |
| 0.244 | 0.029 | 0.244 | Melanin inhibitor | 0.218 0.035 DBMET00686 | ||
| 0.232 | 0.02 | 0.247 | Cell wall synthesis inhibitor | 0.247 0.017 DBMET00686 | DBMET00686 | |
| 0.217 | 0.005 | 0.217 | Sphingosine 1-phosphate receptor 2 antagonist | 0.196 0.009 DBMET00686 | ||
| 0.217 | 0.008 | 0.217 | TRPA1 agonist | 0.19 0.013 DBMET00686 | ||
| 0.218 | 0.008 | 0.301 | HIV-1 integrase (Overall Integration) inhibitor | 0.301 0.004 DBMET00686 | DBMET00686 | |
| 0.248 | 0.041 | 0.386 | Dual specificity phosphatase 3 inhibitor | 0.386 0.015 DBMET00686 | DBMET00686 | |
| 0.267 | 0.061 | 0.267 | Vasodilator | |||
| 0.235 | 0.03 | 0.235 | Cyclooxygenase inhibitor | 0.203 0.041 DBMET00686 | ||
| 0.218 | 0.012 | 0.218 | Catalase inhibitor | 0.205 0.014 DBMET00686 | ||
| 0.246 | 0.042 | 0.246 | P-glycoprotein inhibitor | |||
| 0.264 | 0.066 | 0.264 | Platelet antagonist | |||
| 0.215 | 0.018 | 0.215 | Toll-Like receptor 2 antagonist | 0.188 0.03 DBMET00686 | ||
| 0.213 | 0.017 | 0.389 | Carbonic anhydrase XV inhibitor | 0.389 0.004 DBMET00686 | DBMET00686 | |
| 0.209 | 0.014 | 0.251 | Adenylate kinase inhibitor | 0.251 0.01 DBMET00686 | DBMET00686 | |
| 0.218 | 0.024 | 0.257 | Aldehyde dehydrogenase inhibitor | 0.257 0.017 DBMET00686 | DBMET00686 | |
| 0.218 | 0.029 | 0.268 | NADPH oxidase inhibitor | 0.268 0.017 DBMET00686 | DBMET00686 | |
| 0.215 | 0.027 | 0.235 | ATPase inhibitor | 0.235 0.018 DBMET00686 | DBMET00686 | |
| 0.203 | 0.015 | 0.246 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.246 0.01 DBMET00686 | DBMET00686 | |
| 0.301 | 0.115 | 0.357 | GABA C receptor rho-3 antagonist | 0.357 0.082 DBMET00686 | DBMET00686 | |
| 0.238 | 0.052 | 0.238 | DNA methyltransferase I inhibitor | 0.23 0.055 DBMET00686 | ||
| 0.195 | 0.011 | 0.317 | Creatine kinase inhibitor | 0.317 0.004 DBMET00686 | DBMET00686 | |
| 0.187 | 0.004 | 0.187 | Elastase 1 inhibitor | 0.072 0.044 DBMET00686 | ||
| 0.19 | 0.015 | 0.19 | Photosensitizer | 0.168 0.022 DBMET00686 | ||
| 0.227 | 0.058 | 0.227 | Nitric oxide antagonist | 0.198 0.068 DBMET00686 | ||
| 0.172 | 0.004 | 0.23 | Urate transporter 1 inhibitor | 0.23 0.003 DBMET00686 | DBMET00686 | |
| 0.208 | 0.043 | 0.208 | Antipruritic | 0.184 0.061 DBMET00686 | ||
| 0.211 | 0.047 | 0.212 | Thrombolytic | 0.212 0.047 DBMET00686 | DBMET00686 | |
| 0.168 | 0.005 | 0.168 | Glycine receptor agonist | 0.144 0.008 DBMET00686 | ||
| 0.174 | 0.015 | 0.238 | Heat shock protein 70 antagonist | 0.238 0.004 DBMET00686 | DBMET00686 | |
| 0.207 | 0.048 | 0.21 | 3C-like protease (Human coronavirus) inhibitor | 0.21 0.046 DBMET00686 | DBMET00686 | |
| 0.209 | 0.05 | 0.373 | Dual specificity phosphatase inhibitor | 0.373 0.018 DBMET00686 | DBMET00686 | |
| 0.193 | 0.035 | 0.193 | Hemostatic | 0.157 0.059 DBMET00686 | ||
| 0.187 | 0.031 | 0.191 | CF transmembrane conductance regulator agonist | 0.191 0.027 DBMET00686 | DBMET00686 | |
| 0.183 | 0.028 | 0.201 | Farnesoid X receptor antagonist | 0.201 0.021 DBMET00686 | DBMET00686 | |
| 0.171 | 0.018 | 0.187 | Androgen antagonist | 0.187 0.015 DBMET00686 | DBMET00686 | |
| 0.219 | 0.067 | 0.219 | DNA methylase inhibitor | 0.207 0.075 DBMET00686 | ||
| 0.157 | 0.005 | 0.157 | Peroxisome proliferator-activated receptor gamma antagonist | 0.125 0.009 DBMET00686 | ||
| 0.176 | 0.025 | 0.176 | Beta amyloid protein antagonist | 0.164 0.032 DBMET00686 | ||
| 0.171 | 0.021 | 0.208 | GABA C receptor antagonist | 0.208 0.011 DBMET00686 | DBMET00686 | |
| 0.202 | 0.054 | 0.387 | Mcl-1 antagonist | 0.387 0.012 DBMET00686 | DBMET00686 | |
| 0.188 | 0.04 | 0.188 | Cytokine production inhibitor | 0.181 0.043 DBMET00686 | ||
| 0.152 | 0.005 | 0.279 | Plasminogen activator inhibitor antagonist | 0.279 0.004 DBMET00686 | DBMET00686 | |
| 0.162 | 0.016 | 0.26 | DOPA decarboxylase inhibitor | 0.26 0.003 DBMET00686 | DBMET00686 | |
| 0.191 | 0.046 | 0.191 | Lipid peroxidase inhibitor | 0.177 0.052 DBMET00686 | ||
| 0.149 | 0.004 | 0.149 | Exportin-1 inhibitor | 0.103 0.008 DBMET00686 | ||
| 0.149 | 0.004 | 0.168 | Aconitate hydratase inhibitor | 0.168 0.004 DBMET00686 | DBMET00686 | |
| 0.149 | 0.007 | 0.23 | Purinergic P2X1 antagonist | 0.23 0.003 DBMET00686 | DBMET00686 | |
| 0.156 | 0.015 | 0.157 | Anabolic | 0.157 0.015 DBMET00686 | DBMET00686 | |
| 0.153 | 0.012 | 0.153 | Peroxisome proliferator-activated receptor gamma agonist | 0.14 0.015 DBMET00686 | ||
| 0.152 | 0.012 | 0.152 | Glutathione S-transferase inhibitor | 0.134 0.016 DBMET00686 | ||
| 0.201 | 0.064 | 0.201 | Hepatoprotectant | 0.185 0.075 DBMET00686 | ||
| 0.184 | 0.048 | 0.302 | Catenin beta inhibitor | 0.302 0.005 DBMET00686 | DBMET00686 | |
| 0.16 | 0.025 | 0.16 | Mediator release inhibitor | 0.12 0.048 DBMET00686 | ||
| 0.165 | 0.031 | 0.165 | Microtubule formation inhibitor | 0.118 0.063 DBMET00686 | ||
| 0.146 | 0.012 | 0.154 | Ornithine decarboxylase inhibitor | 0.154 0.01 DBMET00686 | DBMET00686 | |
| 0.14 | 0.007 | 0.14 | Peroxisome proliferator-activated receptor alpha agonist | 0.117 0.009 DBMET00686 | ||
| 0.136 | 0.003 | 0.203 | Adenine nucleotide translocase inhibitor | 0.203 0.002 DBMET00686 | DBMET00686 | |
| 0.137 | 0.005 | 0.137 | Estrogen-related receptor beta agonist | 0.118 0.011 DBMET00686 | ||
| 0.173 | 0.041 | 0.173 | Cyclooxygenase 2 inhibitor | 0.154 0.051 DBMET00686 | ||
| 0.221 | 0.089 | 0.331 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.331 0.055 DBMET00686 | DBMET00686 | |
| 0.145 | 0.013 | 0.168 | Prostaglandin-E synthase inhibitor | 0.168 0.009 DBMET00686 | DBMET00686 | |
| 0.143 | 0.011 | 0.143 | Calcium channel L-type blocker | 0.094 0.028 DBMET00686 | ||
| 0.132 | 0.004 | 0.132 | Retinoid X alpha receptor agonist | 0.124 0.004 DBMET00686 | ||
| 0.146 | 0.019 | 0.24 | Phosphofructokinase-1 inhibitor | 0.24 0.008 DBMET00686 | DBMET00686 | |
| 0.14 | 0.013 | 0.187 | Glutamate release inhibitor | 0.187 0.005 DBMET00686 | DBMET00686 | |
| 0.158 | 0.035 | 0.182 | 5-Lipoxygenase inhibitor | 0.182 0.028 DBMET00686 | DBMET00686 | |
| 0.131 | 0.009 | 0.218 | Xanthine dehydrogenase inhibitor | 0.218 0.004 DBMET00686 | DBMET00686 | |
| 0.127 | 0.007 | 0.127 | NMDA receptor glycine site agonist | 0.116 0.01 DBMET00686 | ||
| 0.131 | 0.012 | 0.176 | Biliverdin reductase inhibitor | 0.176 0.007 DBMET00686 | DBMET00686 | |
| 0.166 | 0.047 | 0.166 | Calcium channel blocker | 0.114 0.095 DBMET00686 | ||
| 0.123 | 0.005 | 0.158 | TRPM8 blocker | 0.158 0.004 DBMET00686 | DBMET00686 | |
| 0.121 | 0.003 | 0.121 | Pregnane X receptor antagonist | 0.105 0.003 DBMET00686 | ||
| 0.124 | 0.008 | 0.124 | Leukocyte elastase inhibitor | 0.049 0.025 DBMET00686 | ||
| 0.127 | 0.012 | 0.127 | NMDA receptor agonist | 0.119 0.013 DBMET00686 | ||
| 0.119 | 0.004 | 0.119 | Peroxisome proliferator-activated receptor alpha antagonist | 0.079 0.005 DBMET00686 | ||
| 0.134 | 0.022 | 0.202 | NADH dehydrogenase inhibitor | 0.202 0.01 DBMET00686 | DBMET00686 | |
| 0.136 | 0.025 | 0.173 | Carbonic anhydrase XIII inhibitor | 0.173 0.018 DBMET00686 | DBMET00686 | |
| 0.121 | 0.009 | 0.121 | Transcription factor AP-1 inhibitor | 0.093 0.015 DBMET00686 | ||
| 0.15 | 0.04 | 0.324 | Cystathionine beta-synthase inhibitor | 0.324 0.008 DBMET00686 | DBMET00686 | |
| 0.134 | 0.024 | 0.164 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.164 0.015 DBMET00686 | DBMET00686 | |
| 0.143 | 0.033 | 0.148 | Caspase 3 inhibitor | 0.148 0.029 DBMET00686 | DBMET00686 | |
| 0.113 | 0.005 | 0.113 | Peroxisome proliferator-activated receptor delta antagonist | 0.083 0.006 DBMET00686 | ||
| 0.144 | 0.038 | 0.235 | Chelator | 0.235 0.019 DBMET00686 | DBMET00686 | |
| 0.131 | 0.026 | 0.179 | Carbonic anhydrase VI inhibitor | 0.179 0.016 DBMET00686 | DBMET00686 | |
| 0.13 | 0.025 | 0.13 | Thioredoxin inhibitor | |||
| 0.108 | 0.004 | 0.168 | Dihydroorotate oxidase inhibitor | 0.168 0.002 DBMET00686 | DBMET00686 | |
| 0.214 | 0.112 | 0.214 | Immunostimulant | 0.203 0.118 DBMET00686 | ||
| 0.165 | 0.065 | 0.184 | Diuretic | 0.184 0.051 DBMET00686 | DBMET00686 | |
| 0.123 | 0.022 | 0.17 | Glutamate dehydrogenase inhibitor | 0.17 0.013 DBMET00686 | DBMET00686 | |
| 0.197 | 0.096 | 0.241 | Angiogenesis stimulant | 0.241 0.074 DBMET00686 | DBMET00686 | |
| 0.116 | 0.016 | 0.116 | Leukotriene antagonist | 0.114 0.017 DBMET00686 | ||
| 0.111 | 0.012 | 0.15 | Neuraminidase inhibitor | 0.15 0.005 DBMET00686 | DBMET00686 | |
| 0.147 | 0.049 | 0.147 | Antibacterial (Helicobacter pylori) | 0.11 0.098 DBMET00686 | ||
| 0.143 | 0.046 | 0.149 | Vanilloid 1 agonist | 0.149 0.039 DBMET00686 | DBMET00686 | |
| 0.102 | 0.004 | 0.102 | Retinoid X receptor agonist | 0.097 0.005 DBMET00686 | ||
| 0.116 | 0.019 | 0.168 | Histone deacetylase stimulant | 0.168 0.007 DBMET00686 | DBMET00686 | |
| 0.116 | 0.019 | 0.168 | Histone deacetylase SIRT1 stimulant | 0.168 0.007 DBMET00686 | DBMET00686 | |
| 0.109 | 0.013 | 0.109 | Prostaglandin E2 antagonist | 0.094 0.016 DBMET00686 | ||
| 0.105 | 0.009 | 0.105 | Elastase inhibitor | 0.051 0.04 DBMET00686 | ||
| 0.103 | 0.008 | 0.103 | Nitric oxide donor | 0.061 0.046 DBMET00686 | ||
| 0.097 | 0.003 | 0.171 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.171 0.002 DBMET00686 | DBMET00686 | |
| 0.117 | 0.023 | 0.13 | Bile acid receptor antagonist | 0.13 0.013 DBMET00686 | DBMET00686 | |
| 0.112 | 0.019 | 0.15 | HIV-1 integrase inhibitor | 0.15 0.008 DBMET00686 | DBMET00686 | |
| 0.108 | 0.016 | 0.108 | Prostaglandin antagonist | 0.082 0.022 DBMET00686 | ||
| 0.107 | 0.014 | 0.157 | Neuraminidase (influenza) inhibitor | 0.157 0.007 DBMET00686 | DBMET00686 | |
| 0.152 | 0.059 | 0.158 | Adenylate cyclase stimulant | 0.158 0.05 DBMET00686 | DBMET00686 | |
| 0.221 | 0.128 | 0.32 | Insulysin inhibitor | 0.32 0.047 DBMET00686 | DBMET00686 | |
| 0.143 | 0.052 | 0.143 | Anesthetic local | 0.103 0.08 DBMET00686 | ||
| 0.111 | 0.02 | 0.111 | Leukotriene synthesis inhibitor | 0.098 0.027 DBMET00686 | ||
| 0.095 | 0.005 | 0.116 | Nicotinic acid receptor agonist | 0.116 0.004 DBMET00686 | DBMET00686 | |
| 0.104 | 0.015 | 0.137 | Maillard reaction inhibitor | 0.137 0.007 DBMET00686 | DBMET00686 | |
| 0.105 | 0.015 | 0.199 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.199 0.004 DBMET00686 | DBMET00686 | |
| 0.182 | 0.095 | 0.182 | Antimitotic | |||
| 0.218 | 0.131 | 0.251 | Hypoxia-inducible factor 1 alpha inhibitor | 0.251 0.1 DBMET00686 | DBMET00686 | |
| 0.136 | 0.049 | 0.156 | CC chemokine 6 receptor antagonist | 0.156 0.016 DBMET00686 | DBMET00686 | |
| 0.12 | 0.035 | 0.12 | Calcium antagonist | |||
| 0.097 | 0.012 | 0.107 | Glutamate (mGluR7) antagonist | 0.107 0.007 DBMET00686 | DBMET00686 | |
| 0.156 | 0.072 | 0.235 | Hexokinase inhibitor | 0.235 0.021 DBMET00686 | DBMET00686 | |
| 0.09 | 0.006 | 0.09 | Lysophosphatidic acid 3 receptor antagonist | 0.09 0.006 DBMET00686 | ||
| 0.103 | 0.02 | 0.103 | Sphingosine 1-phosphate receptor antagonist | 0.101 0.021 DBMET00686 | ||
| 0.088 | 0.005 | 0.088 | Adenylate cyclase 1 inhibitor | 0.079 0.008 DBMET00686 | ||
| 0.099 | 0.017 | 0.132 | GABA B receptor agonist | 0.132 0.005 DBMET00686 | DBMET00686 | |
| 0.088 | 0.007 | 0.088 | Peroxisome proliferator-activated receptor delta agonist | 0.058 0.011 DBMET00686 | ||
| 0.099 | 0.019 | 0.122 | Argininosuccinate synthase inhibitor | 0.122 0.015 DBMET00686 | DBMET00686 | |
| 0.119 | 0.041 | 0.131 | GABA C receptor rho-1 antagonist | 0.131 0.031 DBMET00686 | DBMET00686 | |
| 0.108 | 0.029 | 0.334 | Histidine decarboxylase inhibitor | 0.334 0.005 DBMET00686 | DBMET00686 | |
| 0.143 | 0.065 | 0.213 | Alkaline phosphatase inhibitor | 0.213 0.029 DBMET00686 | DBMET00686 | |
| 0.081 | 0.004 | 0.081 | Cholesterol ester transfer protein antagonist | 0.064 0.004 DBMET00686 | ||
| 0.126 | 0.049 | 0.157 | Aminopeptidase B inhibitor | 0.157 0.035 DBMET00686 | DBMET00686 | |
| 0.08 | 0.004 | 0.08 | Liver X receptor beta antagonist | 0.078 0.004 DBMET00686 | ||
| 0.101 | 0.025 | 0.101 | Sphingosine 1-phosphate receptor 4 agonist | 0.095 0.027 DBMET00686 | ||
| 0.101 | 0.025 | 0.212 | Phenylalanine 4-hydroxylase inhibitor | 0.212 0.006 DBMET00686 | DBMET00686 | |
| 0.093 | 0.018 | 0.097 | Androgen agonist | 0.097 0.016 DBMET00686 | DBMET00686 | |
| 0.151 | 0.077 | 0.39 | Peroxidase inhibitor | 0.39 0.022 DBMET00686 | DBMET00686 | |
| 0.082 | 0.008 | 0.12 | Dihydroorotase inhibitor | 0.12 0.004 DBMET00686 | DBMET00686 | |
| 0.089 | 0.016 | 0.097 | Glutamate (mGluR6) antagonist | 0.097 0.012 DBMET00686 | DBMET00686 | |
| 0.088 | 0.015 | 0.172 | Dihydroorotate dehydrogenase inhibitor | 0.172 0.004 DBMET00686 | DBMET00686 | |
| 0.091 | 0.019 | 0.114 | Acyl-CoA dehydrogenase inhibitor | 0.114 0.013 DBMET00686 | DBMET00686 | |
| 0.211 | 0.14 | 0.323 | 12-Lipoxygenase inhibitor | 0.323 0.068 DBMET00686 | DBMET00686 | |
| 0.114 | 0.043 | 0.114 | Prolactin inhibitor | |||
| 0.084 | 0.014 | 0.084 | Sphingosine 1-phosphate receptor 3 antagonist | 0.075 0.02 DBMET00686 | ||
| 0.078 | 0.008 | 0.103 | Nicotinic acid receptor 2 agonist | 0.103 0.005 DBMET00686 | DBMET00686 | |
| 0.116 | 0.047 | 0.233 | Carbonic anhydrase III inhibitor | 0.233 0.011 DBMET00686 | DBMET00686 | |
| 0.08 | 0.011 | 0.08 | Glucose-6-phosphate translocase inhibitor | 0.076 0.013 DBMET00686 | ||
| 0.074 | 0.005 | 0.154 | Purinergic P2Y14 antagonist | 0.154 0.004 DBMET00686 | DBMET00686 | |
| 0.083 | 0.014 | 0.101 | Leukotriene B4 antagonist | 0.101 0.01 DBMET00686 | DBMET00686 | |
| 0.098 | 0.029 | 0.145 | GABA aminotransferase inhibitor | 0.145 0.009 DBMET00686 | DBMET00686 | |
| 0.071 | 0.003 | 0.071 | Elastase 3B inhibitor | |||
| 0.071 | 0.003 | 0.071 | Elastase 2B inhibitor | |||
| 0.071 | 0.003 | 0.071 | Elastase 3A inhibitor | |||
| 0.171 | 0.103 | 0.173 | Interleukin antagonist | 0.173 0.101 DBMET00686 | DBMET00686 | |
| 0.095 | 0.027 | 0.095 | Carbonic anhydrase VA inhibitor | 0.093 0.028 DBMET00686 | ||
| 0.127 | 0.06 | 0.141 | Sphingosine 1-phosphate receptor 4 antagonist | 0.141 0.042 DBMET00686 | DBMET00686 | |
| 0.07 | 0.006 | 0.135 | Glutamate (mGluR3) antagonist | 0.135 0.004 DBMET00686 | DBMET00686 | |
| 0.08 | 0.015 | 0.097 | Heme oxygenase stimulant | 0.097 0.008 DBMET00686 | DBMET00686 | |
| 0.074 | 0.009 | 0.074 | Factor III inhibitor | 0.063 0.015 DBMET00686 | ||
| 0.157 | 0.093 | 0.235 | Phospholipase C inhibitor | 0.235 0.028 DBMET00686 | DBMET00686 | |
| 0.093 | 0.029 | 0.093 | Carbonic anhydrase V inhibitor | 0.092 0.03 DBMET00686 | ||
| 0.066 | 0.003 | 0.071 | Glutamate (mGluR3) agonist | 0.071 0.003 DBMET00686 | DBMET00686 | |
| 0.138 | 0.076 | 0.248 | Mannose-6-phosphate isomerase inhibitor | 0.248 0.012 DBMET00686 | DBMET00686 | |
| 0.066 | 0.005 | 0.099 | Glutamate (mGluR8) agonist | 0.099 0.003 DBMET00686 | DBMET00686 | |
| 0.074 | 0.013 | 0.074 | 5-Alpha-reductase inhibitor | 0.055 0.017 DBMET00686 | ||
| 0.075 | 0.015 | 0.091 | Topoisomerase II beta inhibitor | 0.091 0.011 DBMET00686 | DBMET00686 | |
| 0.098 | 0.037 | 0.186 | Myeloperoxidase inhibitor | 0.186 0.006 DBMET00686 | DBMET00686 | |
| 0.133 | 0.073 | 0.218 | Amylase inhibitor | 0.218 0.038 DBMET00686 | DBMET00686 | |
| 0.071 | 0.011 | 0.074 | Heparanase inhibitor | 0.074 0.009 DBMET00686 | DBMET00686 | |
| 0.077 | 0.018 | 0.093 | Carbonic anhydrase XIV inhibitor | 0.093 0.013 DBMET00686 | DBMET00686 | |
| 0.091 | 0.032 | 0.091 | Epoxide hydrolase inhibitor | 0.085 0.038 DBMET00686 | ||
| 0.066 | 0.007 | 0.081 | Retinoic acid alpha receptor agonist | 0.081 0.005 DBMET00686 | DBMET00686 | |
| 0.077 | 0.02 | 0.1 | Potassium channel intermediate-conductance Ca-activated blocker | 0.1 0.009 DBMET00686 | DBMET00686 | |
| 0.08 | 0.023 | 0.096 | Prostaglandin F2 alpha antagonist | 0.096 0.013 DBMET00686 | DBMET00686 | |
| 0.082 | 0.025 | 0.082 | Prostaglandin EP2 antagonist | 0.079 0.027 DBMET00686 | ||
| 0.068 | 0.012 | 0.068 | Sphingosine 1-phosphate receptor agonist | 0.061 0.016 DBMET00686 | ||
| 0.061 | 0.006 | 0.064 | Retinoid X receptor antagonist | 0.064 0.005 DBMET00686 | DBMET00686 | |
| 0.116 | 0.061 | 0.116 | Calcium channel (voltage-sensitive) blocker | |||
| 0.089 | 0.034 | 0.107 | Aminopeptidase I inhibitor | 0.107 0.025 DBMET00686 | DBMET00686 | |
| 0.06 | 0.005 | 0.06 | Free fatty acid receptor 1 antagonist | 0.054 0.007 DBMET00686 | ||
| 0.142 | 0.088 | 0.194 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.194 0.022 DBMET00686 | DBMET00686 | |
| 0.072 | 0.018 | 0.072 | Diacylglycerol O-acyltransferase inhibitor | 0.072 0.018 DBMET00686 | ||
| 0.074 | 0.021 | 0.075 | Sphingosine kinase inhibitor | 0.075 0.019 DBMET00686 | DBMET00686 | |
| 0.064 | 0.011 | 0.095 | Glutamate (mGluR group III) antagonist | 0.095 0.005 DBMET00686 | DBMET00686 | |
| 0.064 | 0.011 | 0.071 | Liver X receptor alpha agonist | 0.071 0.009 DBMET00686 | DBMET00686 | |
| 0.12 | 0.067 | 0.155 | Topoisomerase II inhibitor | 0.155 0.047 DBMET00686 | DBMET00686 | |
| 0.075 | 0.023 | 0.075 | Thromboxane antagonist | 0.068 0.027 DBMET00686 | ||
| 0.077 | 0.025 | 0.089 | MDM2 inhibitor | 0.089 0.012 DBMET00686 | DBMET00686 | |
| 0.136 | 0.084 | 0.136 | Pregnane X receptor agonist | 0.133 0.092 DBMET00686 | ||
| 0.068 | 0.016 | 0.074 | Leukotriene C antagonist | 0.074 0.011 DBMET00686 | DBMET00686 | |
| 0.069 | 0.018 | 0.09 | DNA helicase inhibitor | 0.09 0.008 DBMET00686 | DBMET00686 | |
| 0.089 | 0.038 | 0.089 | Cathepsin G inhibitor | |||
| 0.06 | 0.009 | 0.09 | Nerve growth factor antagonist | 0.09 0.004 DBMET00686 | DBMET00686 | |
| 0.086 | 0.036 | 0.13 | Nav1.8 sodium channel blocker | 0.13 0.018 DBMET00686 | DBMET00686 | |
| 0.115 | 0.066 | 0.115 | Interleukin 1b antagonist | |||
| 0.062 | 0.013 | 0.094 | Glutamate (mGluR4) antagonist | 0.094 0.006 DBMET00686 | DBMET00686 | |
| 0.091 | 0.044 | 0.122 | Glutamate receptor agonist | 0.122 0.026 DBMET00686 | DBMET00686 | |
| 0.092 | 0.045 | 0.092 | Inducible nitric-oxide synthase inhibitor | |||
| 0.115 | 0.068 | 0.143 | Interleukin 8 antagonist | 0.143 0.039 DBMET00686 | DBMET00686 | |
| 0.053 | 0.005 | 0.054 | Retinoid X alpha receptor antagonist | 0.054 0.005 DBMET00686 | DBMET00686 | |
| 0.062 | 0.015 | 0.137 | Kainate receptor antagonist | 0.137 0.005 DBMET00686 | DBMET00686 | |
| 0.051 | 0.005 | 0.051 | Prostaglandin EP2 agonist | 0.047 0.006 DBMET00686 | ||
| 0.074 | 0.029 | 0.088 | TRPA1 antagonist | 0.088 0.021 DBMET00686 | DBMET00686 | |
| 0.105 | 0.061 | 0.163 | Urease inhibitor | 0.163 0.018 DBMET00686 | DBMET00686 | |
| 0.058 | 0.014 | 0.059 | Neuraminidase (Influenza A) inhibitor | 0.059 0.014 DBMET00686 | DBMET00686 | |
| 0.049 | 0.005 | 0.049 | Retinoid X beta receptor agonist | 0.046 0.005 DBMET00686 | ||
| 0.053 | 0.009 | 0.053 | Prostaglandin agonist | 0.052 0.01 DBMET00686 | ||
| 0.051 | 0.008 | 0.066 | Prostaglandin EP4 antagonist | 0.066 0.006 DBMET00686 | DBMET00686 | |
| 0.066 | 0.024 | 0.066 | Ryanodine receptor antagonist | 0.064 0.028 DBMET00686 | ||
| 0.057 | 0.015 | 0.057 | Sphingosine 1-phosphate receptor 1 agonist | 0.048 0.022 DBMET00686 | ||
| 0.047 | 0.005 | 0.047 | Elastase 2 inhibitor | |||
| 0.047 | 0.005 | 0.047 | Elastase 2A inhibitor | |||
| 0.062 | 0.02 | 0.241 | CD45 antagonist | 0.241 0.004 DBMET00686 | DBMET00686 | |
| 0.046 | 0.005 | 0.056 | Retinoic acid receptor agonist | 0.056 0.005 DBMET00686 | DBMET00686 | |
| 0.048 | 0.007 | 0.048 | Kynurenine 3 monooxygenase inhibitor | 0.048 0.007 DBMET00686 | ||
| 0.065 | 0.025 | 0.065 | Thromboxane A2 antagonist | 0.064 0.025 DBMET00686 | ||
| 0.06 | 0.02 | 0.065 | Adenosine deaminase inhibitor | 0.065 0.017 DBMET00686 | DBMET00686 | |
| 0.068 | 0.028 | 0.074 | Aldose reductase inhibitor | 0.074 0.026 DBMET00686 | DBMET00686 | |
| 0.063 | 0.025 | 0.078 | Sphingosine 1-phosphate receptor 1 antagonist | 0.078 0.015 DBMET00686 | DBMET00686 | |
| 0.051 | 0.014 | 0.061 | Farnesoid X receptor agonist | 0.061 0.01 DBMET00686 | DBMET00686 | |
| 0.047 | 0.009 | 0.047 | Uridine phosphorylase inhibitor | 0.046 0.009 DBMET00686 | ||
| 0.05 | 0.013 | 0.062 | Fumarate hydratase inhibitor | 0.062 0.01 DBMET00686 | DBMET00686 | |
| 0.144 | 0.108 | 0.144 | Tumour necrosis factor antagonist | |||
| 0.151 | 0.115 | 0.151 | Psychostimulant | |||
| 0.176 | 0.14 | 0.176 | Spasmolytic | 0.17 0.145 DBMET00686 | ||
| 0.051 | 0.015 | 0.067 | GABA uptake inhibitor | 0.067 0.008 DBMET00686 | DBMET00686 | |
| 0.042 | 0.007 | 0.042 | Retinoid X gamma receptor agonist | 0.039 0.007 DBMET00686 | ||
| 0.13 | 0.096 | 0.149 | Thiol protease inhibitor | 0.149 0.069 DBMET00686 | DBMET00686 | |
| 0.041 | 0.007 | 0.057 | Calcium-sensing receptor agonist | 0.057 0.005 DBMET00686 | DBMET00686 | |
| 0.05 | 0.016 | 0.06 | Glutamate (mGluR group II) antagonist | 0.06 0.011 DBMET00686 | DBMET00686 | |
| 0.044 | 0.01 | 0.048 | Lysophosphatidic acid 2 receptor antagonist | 0.048 0.009 DBMET00686 | DBMET00686 | |
| 0.05 | 0.017 | 0.076 | Dihydropteroate synthase inhibitor | 0.076 0.007 DBMET00686 | DBMET00686 | |
| 0.055 | 0.022 | 0.055 | Microtubule stabilization | |||
| 0.133 | 0.1 | 0.145 | GABA C receptor rho-2 antagonist | 0.145 0.08 DBMET00686 | DBMET00686 | |
| 0.086 | 0.053 | 0.086 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.05 | 0.017 | 0.05 | Dopamine D5 agonist | 0.047 0.019 DBMET00686 | ||
| 0.048 | 0.016 | 0.048 | Arginase inhibitor | 0.04 0.022 DBMET00686 | ||
| 0.044 | 0.012 | 0.052 | Glutamate (mGluR8) antagonist | 0.052 0.008 DBMET00686 | DBMET00686 | |
| 0.086 | 0.053 | 0.137 | D-Ala-D-Ala ligase inhibitor | 0.137 0.008 DBMET00686 | DBMET00686 | |
| 0.046 | 0.014 | 0.05 | Leukotriene C4 antagonist | 0.05 0.01 DBMET00686 | DBMET00686 | |
| 0.045 | 0.014 | 0.045 | Vanilloid 3 antagonist | 0.042 0.018 DBMET00686 | ||
| 0.047 | 0.017 | 0.073 | Glutamate (mGluR group II) agonist | 0.073 0.01 DBMET00686 | DBMET00686 | |
| 0.086 | 0.055 | 0.137 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.137 0.018 DBMET00686 | DBMET00686 | |
| 0.04 | 0.009 | 0.044 | Liver X receptor alpha antagonist | 0.044 0.007 DBMET00686 | DBMET00686 | |
| 0.037 | 0.006 | 0.062 | Glutamate (mGluR1) agonist | 0.062 0.004 DBMET00686 | DBMET00686 | |
| 0.042 | 0.012 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.009 DBMET00686 | DBMET00686 | |
| 0.046 | 0.017 | 0.046 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.024 DBMET00686 | ||
| 0.036 | 0.006 | 0.061 | Prostaglandin EP4 agonist | 0.061 0.004 DBMET00686 | DBMET00686 | |
| 0.034 | 0.005 | 0.034 | Lysophosphatidic acid 1 receptor antagonist | 0.027 0.008 DBMET00686 | ||
| 0.047 | 0.018 | 0.05 | Kainate receptor agonist | 0.05 0.014 DBMET00686 | DBMET00686 | |
| 0.042 | 0.014 | 0.049 | Liver X receptor beta agonist | 0.049 0.011 DBMET00686 | DBMET00686 | |
| 0.041 | 0.013 | 0.051 | Liver X receptor antagonist | 0.051 0.009 DBMET00686 | DBMET00686 | |
| 0.054 | 0.026 | 0.054 | Potassium channel Kv1.3 blocker | |||
| 0.058 | 0.03 | 0.071 | Autotaxin inhibitor | 0.071 0.022 DBMET00686 | DBMET00686 | |
| 0.038 | 0.01 | 0.087 | NMDA 2D receptor antagonist | 0.087 0.004 DBMET00686 | DBMET00686 | |
| 0.033 | 0.005 | 0.051 | Retinoic acid alpha receptor antagonist | 0.051 0.004 DBMET00686 | DBMET00686 | |
| 0.043 | 0.016 | 0.077 | RNA-directed RNA polymerase inhibitor | 0.077 0.007 DBMET00686 | DBMET00686 | |
| 0.034 | 0.006 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 DBMET00686 | DBMET00686 | |
| 0.035 | 0.008 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.045 0.004 DBMET00686 | DBMET00686 | |
| 0.118 | 0.091 | 0.118 | Interleukin 1 antagonist | |||
| 0.032 | 0.005 | 0.036 | Retinoic acid gamma receptor agonist | 0.036 0.005 DBMET00686 | DBMET00686 | |
| 0.043 | 0.017 | 0.076 | CF transmembrane conductance regulator antagonist | 0.076 0.003 DBMET00686 | DBMET00686 | |
| 0.031 | 0.005 | 0.047 | Retinoic acid receptor antagonist | 0.047 0.004 DBMET00686 | DBMET00686 | |
| 0.089 | 0.062 | 0.132 | Potassium channel activator | 0.132 0.026 DBMET00686 | DBMET00686 | |
| 0.098 | 0.072 | 0.144 | Beta glucuronidase inhibitor | 0.144 0.028 DBMET00686 | DBMET00686 | |
| 0.041 | 0.015 | 0.051 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.051 0.009 DBMET00686 | DBMET00686 | |
| 0.066 | 0.041 | 0.066 | Interferon inducer | |||
| 0.079 | 0.053 | 0.079 | Interferon agonist | |||
| 0.056 | 0.031 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | 0.05 0.047 DBMET00686 | ||
| 0.052 | 0.027 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.064 0.016 DBMET00686 | DBMET00686 | |
| 0.032 | 0.008 | 0.043 | Leukotriene B4 receptor 2 antagonist | 0.043 0.005 DBMET00686 | DBMET00686 | |
| 0.029 | 0.005 | 0.029 | Retinoid X beta receptor antagonist | 0.029 0.005 DBMET00686 | ||
| 0.058 | 0.035 | 0.058 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.041 | 0.017 | 0.066 | Glutamate (mGluR2) agonist | 0.066 0.01 DBMET00686 | DBMET00686 | |
| 0.05 | 0.027 | 0.066 | Carbonic anhydrase VII inhibitor | 0.066 0.017 DBMET00686 | DBMET00686 | |
| 0.027 | 0.006 | 0.027 | Progesterone receptor B antagonist | 0.025 0.007 DBMET00686 | ||
| 0.03 | 0.009 | 0.05 | Glutamate (mGluR1a) agonist | 0.05 0.005 DBMET00686 | DBMET00686 | |
| 0.047 | 0.026 | 0.056 | Liver X receptor agonist | 0.056 0.019 DBMET00686 | DBMET00686 | |
| 0.031 | 0.011 | 0.032 | Retinoid X gamma receptor antagonist | 0.032 0.01 DBMET00686 | DBMET00686 | |
| 0.03 | 0.01 | 0.073 | Kainate receptor 1 antagonist | 0.073 0.004 DBMET00686 | DBMET00686 | |
| 0.031 | 0.01 | 0.038 | Prostaglandin E2 agonist | 0.038 0.008 DBMET00686 | DBMET00686 | |
| 0.029 | 0.009 | 0.029 | 5-Alpha-reductase 1 inhibitor | 0.024 0.01 DBMET00686 | ||
| 0.027 | 0.007 | 0.028 | Retinoic acid beta receptor agonist | 0.028 0.006 DBMET00686 | DBMET00686 | |
| 0.034 | 0.014 | 0.034 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.031 0.016 DBMET00686 | ||
| 0.049 | 0.03 | 0.049 | Benzodiazepine antagonist | |||
| 0.05 | 0.031 | 0.051 | Dopamine beta hydroxylase inhibitor | 0.051 0.029 DBMET00686 | DBMET00686 | |
| 0.028 | 0.01 | 0.043 | Prostaglandin F2 alpha agonist | 0.043 0.005 DBMET00686 | DBMET00686 | |
| 0.025 | 0.007 | 0.025 | G-protein-coupled receptor 120 agonist | 0.021 0.009 DBMET00686 | ||
| 0.055 | 0.037 | 0.058 | Thromboxane synthase inhibitor | 0.058 0.031 DBMET00686 | DBMET00686 | |
| 0.03 | 0.013 | 0.037 | Prostaglandin H2 antagonist | 0.037 0.007 DBMET00686 | DBMET00686 | |
| 0.212 | 0.195 | 0.317 | Antiobesity | 0.317 0.105 DBMET00686 | DBMET00686 | |
| 0.032 | 0.016 | 0.047 | Leukotriene B4 receptor 1 antagonist | 0.047 0.008 DBMET00686 | DBMET00686 | |
| 0.036 | 0.02 | 0.036 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.082 | 0.066 | 0.082 | Vanilloid agonist | |||
| 0.053 | 0.037 | 0.066 | Ornithine carbamoyltransferase inhibitor | 0.066 0.028 DBMET00686 | DBMET00686 | |
| 0.035 | 0.02 | 0.035 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.019 DBMET00686 | ||
| 0.083 | 0.068 | 0.097 | Granulocyte macrophage colony stimulating factor agonist | 0.097 0.04 DBMET00686 | DBMET00686 | |
| 0.027 | 0.014 | 0.027 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.016 DBMET00686 | ||
| 0.062 | 0.049 | 0.066 | Calcium channel P-type blocker | 0.066 0.037 DBMET00686 | DBMET00686 | |
| 0.054 | 0.041 | 0.075 | Carbonic anhydrase VB inhibitor | 0.075 0.025 DBMET00686 | DBMET00686 | |
| 0.115 | 0.103 | 0.142 | Neurotrophic factor | 0.142 0.067 DBMET00686 | DBMET00686 | |
| 0.017 | 0.005 | 0.038 | Retinoic acid beta receptor antagonist | 0.038 0.004 DBMET00686 | DBMET00686 | |
| 0.078 | 0.066 | 0.078 | Thioredoxin reductase inhibitor | |||
| 0.023 | 0.011 | 0.026 | 5-Alpha-reductase 2 inhibitor | 0.026 0.01 DBMET00686 | DBMET00686 | |
| 0.043 | 0.031 | 0.051 | Guanylate cyclase stimulant | 0.051 0.019 DBMET00686 | DBMET00686 | |
| 0.087 | 0.076 | 0.093 | Interleukin 1 beta converting enzyme inhibitor | 0.093 0.068 DBMET00686 | DBMET00686 | |
| 0.022 | 0.01 | 0.022 | Caspase 8 inhibitor | 0.02 0.012 DBMET00686 | ||
| 0.042 | 0.031 | 0.061 | Guanylate cyclase inhibitor | 0.061 0.01 DBMET00686 | DBMET00686 | |
| 0.015 | 0.005 | 0.031 | Retinoic acid receptor gamma antagonist | 0.031 0.004 DBMET00686 | DBMET00686 | |
| 0.032 | 0.021 | 0.064 | HCV NS5B polymerase inhibitor | 0.064 0.008 DBMET00686 | DBMET00686 | |
| 0.057 | 0.047 | 0.079 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 DBMET00686 | DBMET00686 | |
| 0.078 | 0.068 | 0.154 | NMDA receptor antagonist | 0.154 0.023 DBMET00686 | DBMET00686 | |
| 0.03 | 0.02 | 0.035 | Glutamate (mGluR2) antagonist | 0.035 0.015 DBMET00686 | DBMET00686 | |
| 0.093 | 0.083 | 0.093 | Toll-Like receptor 4 antagonist | |||
| 0.04 | 0.031 | 0.043 | Sphingosine kinase 1 inhibitor | 0.043 0.025 DBMET00686 | DBMET00686 | |
| 0.015 | 0.006 | 0.029 | Glutamate (mGluR6) agonist | 0.029 0.003 DBMET00686 | DBMET00686 | |
| 0.043 | 0.034 | 0.056 | Purinergic P2Y antagonist | 0.056 0.022 DBMET00686 | DBMET00686 | |
| 0.032 | 0.023 | 0.068 | Estrogen-related receptor alpha antagonist | 0.068 0.01 DBMET00686 | DBMET00686 | |
| 0.034 | 0.026 | 0.054 | Kainate receptor 2 antagonist | 0.054 0.014 DBMET00686 | DBMET00686 | |
| 0.04 | 0.033 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.034 DBMET00686 | ||
| 0.013 | 0.006 | 0.052 | Thrombopoietin agonist | 0.052 0.002 DBMET00686 | DBMET00686 | |
| 0.027 | 0.02 | 0.033 | LFA antagonist | 0.033 0.012 DBMET00686 | DBMET00686 | |
| 0.024 | 0.017 | 0.039 | NMDA receptor glycine site antagonist | 0.039 0.009 DBMET00686 | DBMET00686 | |
| 0.028 | 0.021 | 0.039 | Estrogen-related receptor gamma antagonist | 0.039 0.005 DBMET00686 | DBMET00686 | |
| 0.041 | 0.034 | 0.049 | GABA B receptor antagonist | 0.049 0.021 DBMET00686 | DBMET00686 | |
| 0.06 | 0.054 | 0.078 | Transcription factor RelA inhibitor | 0.078 0.019 DBMET00686 | DBMET00686 | |
| 0.058 | 0.052 | 0.058 | Caspase 9 inhibitor | |||
| 0.024 | 0.019 | 0.036 | Methionyl aminopeptidase 2 inhibitor | 0.036 0.011 DBMET00686 | DBMET00686 | |
| 0.014 | 0.009 | 0.014 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 DBMET00686 | ||
| 0.02 | 0.014 | 0.026 | Prostaglandin EP1 antagonist | 0.026 0.011 DBMET00686 | DBMET00686 | |
| 0.055 | 0.049 | 0.055 | Lipocortins synthesis agonist | |||
| 0.037 | 0.032 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.044 | 0.04 | 0.044 | Mineralocorticoid receptor antagonist | 0.044 0.041 DBMET00686 | ||
| 0.018 | 0.014 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.013 DBMET00686 | ||
| 0.02 | 0.016 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.023 0.01 DBMET00686 | DBMET00686 | |
| 0.01 | 0.006 | 0.01 | Progesterone receptor A antagonist | |||
| 0.07 | 0.067 | 0.101 | Estrogen receptor alpha antagonist | 0.101 0.027 DBMET00686 | DBMET00686 | |
| 0.045 | 0.044 | 0.045 | Prolyl endopeptidase inhibitor | |||
| 0.023 | 0.021 | 0.023 | Leukotriene D4 antagonist | |||
| 0.03 | 0.029 | 0.04 | Catechol O-methyltransferase inhibitor | 0.04 0.014 DBMET00686 | DBMET00686 | |
| 0.057 | 0.056 | 0.057 | CDC25B inhibitor | |||
| 0.076 | 0.075 | 0.078 | Ca(v)3.1 blocker | 0.078 0.067 DBMET00686 | DBMET00686 | |
| 0.005 | 0.005 | 0.01 | Insulin like growth factor 3 antagonist | 0.01 0.003 DBMET00686 | DBMET00686 | |
| 0.017 | 0.017 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.012 DBMET00686 | DBMET00686 | |
| 0.048 | 0.049 | 0.082 | CC chemokine 2 receptor antagonist | 0.082 0.018 DBMET00686 | DBMET00686 | |
| 0.028 | 0.029 | 0.046 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.046 0.013 DBMET00686 | DBMET00686 | |
| 0.084 | 0.086 | 0.129 | Interleukin 12 antagonist | 0.129 0.022 DBMET00686 | DBMET00686 | |
| 0.02 | 0.022 | 0.03 | Beta 1 adrenoreceptor agonist | 0.03 0.008 DBMET00686 | DBMET00686 | |
| 0.006 | 0.009 | 0.009 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 DBMET00686 | DBMET00686 | |
| 0.099 | 0.102 | 0.138 | Estrogen antagonist | 0.138 0.03 DBMET00686 | DBMET00686 | |
| 0.022 | 0.027 | 0.04 | Thyroid hormone agonist | 0.04 0.006 DBMET00686 | DBMET00686 | |
| 0.049 | 0.054 | 0.065 | Fatty acid synthase inhibitor | 0.065 0.03 DBMET00686 | DBMET00686 | |
| 0.056 | 0.062 | 0.063 | Beta adrenoreceptor antagonist | 0.063 0.05 DBMET00686 | DBMET00686 | |
| 0.026 | 0.033 | 0.037 | ATP citrate lysase inhibitor | 0.037 0.016 DBMET00686 | DBMET00686 | |
| 0.062 | 0.068 | 0.07 | Na+ K+ transporting ATPase inhibitor | 0.07 0.06 DBMET00686 | DBMET00686 | |
| 0.009 | 0.016 | 0.012 | CD80 antagonist | 0.012 0.006 DBMET00686 | DBMET00686 | |
| 0.034 | 0.041 | 0.039 | Neurokinin 1 antagonist | 0.039 0.03 DBMET00686 | DBMET00686 | |
| 0.09 | 0.098 | 0.168 | DNA polymerase I inhibitor | 0.168 0.04 DBMET00686 | DBMET00686 | |
| 0.032 | 0.04 | 0.078 | Estradiol 17 beta-dehydrogenase inhibitor | 0.078 0.014 DBMET00686 | DBMET00686 | |
| 0.009 | 0.017 | 0.026 | Egl nine homolog 3 inhibitor | 0.026 0.004 DBMET00686 | DBMET00686 | |
| 0.041 | 0.051 | 0.052 | Beta adrenoreceptor agonist | 0.052 0.014 DBMET00686 | DBMET00686 | |
| 0.01 | 0.02 | 0.041 | Egl nine homolog 1 inhibitor | 0.041 0.004 DBMET00686 | DBMET00686 | |
| 0.019 | 0.029 | 0.028 | ICAM 1 antagonist | 0.028 0.008 DBMET00686 | DBMET00686 | |
| 0.192 | 0.204 | 0.291 | Interleukin 2 agonist | 0.291 0.08 DBMET00686 | DBMET00686 | |
| 0.044 | 0.056 | 0.125 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.125 0.007 DBMET00686 | DBMET00686 | |
| 0.049 | 0.061 | 0.091 | Purinergic P2X2 antagonist | 0.091 0.035 DBMET00686 | DBMET00686 | |
| 0.005 | 0.018 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 DBMET00686 | DBMET00686 | |
| 0.035 | 0.049 | 0.059 | Estrogen agonist | 0.059 0.03 DBMET00686 | DBMET00686 | |
| 0.014 | 0.027 | 0.018 | CXC chemokine 5 receptor antagonist | 0.018 0.013 DBMET00686 | DBMET00686 | |
| 0.042 | 0.056 | 0.056 | Squalene epoxidase inhibitor | 0.056 0.025 DBMET00686 | DBMET00686 | |
| 0.077 | 0.093 | 0.09 | Sphingomyelinase inhibitor | 0.09 0.072 DBMET00686 | DBMET00686 | |
| 0.024 | 0.043 | 0.045 | Phosphoglycerate kinase inhibitor | 0.045 0.016 DBMET00686 | DBMET00686 | |
| 0.112 | 0.132 | 0.18 | NOS3 expression enhancer | 0.18 0.05 DBMET00686 | DBMET00686 | |
| 0.192 | 0.212 | 0.263 | Toll-Like receptor 7 agonist | 0.263 0.136 DBMET00686 | DBMET00686 | |
| 0.011 | 0.031 | 0.028 | Nicotinic acid receptor 1 antagonist | 0.028 0.005 DBMET00686 | DBMET00686 | |
| 0.031 | 0.051 | 0.069 | Phosphorylase inhibitor | 0.069 0.021 DBMET00686 | DBMET00686 | |
| 0.055 | 0.076 | 0.068 | Beta 2 adrenoreceptor agonist | 0.068 0.024 DBMET00686 | DBMET00686 | |
| 0.093 | 0.115 | 0.173 | M17 leucyl aminopeptidase inhibitor | 0.173 0.043 DBMET00686 | DBMET00686 | |
| 0.05 | 0.073 | 0.095 | Lipase inhibitor | 0.095 0.03 DBMET00686 | DBMET00686 | |
| 0.031 | 0.054 | 0.049 | Carbonic anhydrase XII inhibitor | 0.049 0.039 DBMET00686 | DBMET00686 | |
| 0.072 | 0.095 | 0.085 | Interleukin 5 antagonist | 0.085 0.063 DBMET00686 | DBMET00686 | |
| 0.043 | 0.067 | 0.066 | Sphingosine kinase 2 inhibitor | 0.066 0.025 DBMET00686 | DBMET00686 | |
| 0.037 | 0.061 | 0.049 | Aldosterone antagonist | 0.049 0.031 DBMET00686 | DBMET00686 | |
| 0.033 | 0.06 | 0.049 | AICAR transformylase inhibitor | 0.049 0.023 DBMET00686 | DBMET00686 | |
| 0.041 | 0.069 | 0.054 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 DBMET00686 | DBMET00686 | |
| 0.01 | 0.04 | 0.018 | Kainate receptor 5 antagonist | 0.018 0.017 DBMET00686 | DBMET00686 | |
| 0.081 | 0.114 | 0.089 | Glutamate (mGluR7) agonist | 0.089 0.087 DBMET00686 | DBMET00686 | |
| 0.186 | 0.22 | 0.252 | Toll-Like receptor agonist | 0.252 0.146 DBMET00686 | DBMET00686 | |
| 0.009 | 0.043 | 0.02 | Thyroid hormone alpha antagonist | 0.02 0.007 DBMET00686 | DBMET00686 | |
| 0.129 | 0.164 | 0.156 | Neurotensin receptor agonist | 0.156 0.088 DBMET00686 | DBMET00686 | |
| 0.033 | 0.069 | 0.051 | DNA gyrase subunit A inhibitor | 0.051 0.016 DBMET00686 | DBMET00686 | |
| 0.093 | 0.131 | 0.116 | Transcription factor STAT6 inhibitor | 0.116 0.067 DBMET00686 | DBMET00686 | |
| 0.084 | 0.125 | 0.105 | Calcium channel N-type blocker | 0.105 0.087 DBMET00686 | DBMET00686 | |
| 0.014 | 0.055 | 0.032 | Glucagon receptor antagonist | 0.032 0.018 DBMET00686 | DBMET00686 | |
| 0.051 | 0.092 | 0.074 | Topoisomerase II alpha inhibitor | 0.074 0.058 DBMET00686 | DBMET00686 | |
| 0.031 | 0.073 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 DBMET00686 | DBMET00686 | |
| 0.107 | 0.149 | 0.237 | Amyloid beta aggregation inhibitor | 0.237 0.062 DBMET00686 | DBMET00686 | |
| 0.033 | 0.076 | 0.054 | Cholesterol esterase inhibitor | 0.054 0.024 DBMET00686 | DBMET00686 | |
| 0.057 | 0.101 | 0.113 | Adrenaline agonist | 0.113 0.029 DBMET00686 | DBMET00686 | |
| 0.056 | 0.1 | 0.116 | Bcr-Abl kinase inhibitor | 0.116 0.029 DBMET00686 | DBMET00686 | |
| 0.026 | 0.072 | 0.04 | Nicotinic acid receptor 1 agonist | 0.04 0.028 DBMET00686 | DBMET00686 | |
| 0.16 | 0.206 | 0.197 | Neuropeptide Y2 antagonist | 0.197 0.125 DBMET00686 | DBMET00686 | |
| 0.076 | 0.124 | 0.089 | Phosphodiesterase 6D inhibitor | 0.089 0.077 DBMET00686 | DBMET00686 | |
| 0.046 | 0.095 | 0.063 | Aryl hydrocarbon receptor antagonist | 0.063 0.048 DBMET00686 | DBMET00686 | |
| 0.105 | 0.16 | 0.18 | Heat shock protein 90 alpha antagonist | 0.18 0.063 DBMET00686 | DBMET00686 | |
| 0.023 | 0.078 | 0.093 | NMDA 2A receptor antagonist | 0.093 0.015 DBMET00686 | DBMET00686 | |
| 0.025 | 0.08 | 0.059 | NMDA receptor subunit 3B antagonist | 0.059 0.02 DBMET00686 | DBMET00686 | |
| 0.014 | 0.07 | 0.036 | Protocollagen prolyl hydroxylase inhibitor | 0.036 0.009 DBMET00686 | DBMET00686 | |
| 0.021 | 0.079 | 0.033 | Ceramide glucosyltransferase inhibitor | 0.033 0.031 DBMET00686 | DBMET00686 | |
| 0.025 | 0.084 | 0.046 | Mannosidase inhibitor | 0.046 0.03 DBMET00686 | DBMET00686 | |
| 0.018 | 0.077 | 0.052 | NMDA receptor subunit 3A antagonist | 0.052 0.019 DBMET00686 | DBMET00686 | |
| 0.111 | 0.17 | 0.138 | Interleukin 6 antagonist | 0.138 0.109 DBMET00686 | DBMET00686 | |
| 0.025 | 0.085 | 0.038 | AMPA 4 receptor antagonist | 0.038 0.029 DBMET00686 | DBMET00686 | |
| 0.026 | 0.087 | 0.049 | Glutamate (mGluR group III) agonist | 0.049 0.024 DBMET00686 | DBMET00686 | |
| 0.034 | 0.096 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET00686 | DBMET00686 | |
| 0.057 | 0.12 | 0.135 | Protein kinase (CK2) inhibitor | 0.135 0.04 DBMET00686 | DBMET00686 | |
| 0.051 | 0.115 | 0.089 | Ca(v)2.2 blocker | 0.089 0.057 DBMET00686 | DBMET00686 | |
| 0.175 | 0.24 | 0.27 | 15-Lipoxygenase inhibitor | 0.27 0.149 DBMET00686 | DBMET00686 | |
| 0.022 | 0.088 | 0.032 | Glutamate (mGluR4) agonist | 0.032 0.027 DBMET00686 | DBMET00686 | |
| 0.022 | 0.094 | 0.042 | Protein kinase (CK2) beta inhibitor | 0.042 0.011 DBMET00686 | DBMET00686 | |
| 0.067 | 0.141 | 0.235 | M18 aspartyl aminopeptidase inhibitor | 0.235 0.024 DBMET00686 | DBMET00686 | |
| 0.031 | 0.106 | 0.052 | Alpha-mannosidase inhibitor | 0.052 0.04 DBMET00686 | DBMET00686 | |
| 0.035 | 0.11 | 0.052 | Epithelial sodium channel blocker | 0.052 0.044 DBMET00686 | DBMET00686 | |
| 0.107 | 0.187 | 0.215 | I kappa B kinase epsilon inhibitor | 0.215 0.059 DBMET00686 | DBMET00686 | |
| 0.03 | 0.115 | 0.14 | NMDA 2 receptor antagonist | 0.14 0.019 DBMET00686 | DBMET00686 | |
| 0.005 | 0.092 | 0.025 | AMPA 1 receptor antagonist | 0.025 0.023 DBMET00686 | DBMET00686 | |
| 0.041 | 0.129 | 0.113 | MAO B inhibitor | 0.113 0.054 DBMET00686 | DBMET00686 | |
| 0.022 | 0.111 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.016 DBMET00686 | DBMET00686 | |
| 0.056 | 0.147 | 0.121 | Protein kinase (CK2) alpha inhibitor | 0.121 0.061 DBMET00686 | DBMET00686 | |
| 0.024 | 0.118 | 0.063 | NMDA 2C receptor antagonist | 0.063 0.041 DBMET00686 | DBMET00686 | |
| 0.009 | 0.103 | 0.024 | CXC chemokine 2 receptor antagonist | 0.024 0.022 DBMET00686 | DBMET00686 | |
| 0.06 | 0.157 | 0.126 | Estrogen receptor beta antagonist | 0.126 0.026 DBMET00686 | DBMET00686 | |
| 0.005 | 0.109 | 0.029 | Estrogen receptor beta agonist | 0.029 0.024 DBMET00686 | DBMET00686 | |
| 0.116 | 0.222 | 0.284 | Streptokinase A inhibitor | 0.284 0.086 DBMET00686 | DBMET00686 | |
| 0.029 | 0.135 | 0.048 | Factor IXa inhibitor | 0.048 0.04 DBMET00686 | DBMET00686 | |
| 0.015 | 0.127 | 0.046 | AMPA receptor antagonist | 0.046 0.035 DBMET00686 | DBMET00686 | |
| 0.057 | 0.17 | 0.084 | mTOR complex 2 inhibitor | 0.084 0.059 DBMET00686 | DBMET00686 | |
| 0.052 | 0.165 | 0.104 | MAO inhibitor | 0.104 0.086 DBMET00686 | DBMET00686 | |
| 0.083 | 0.201 | 0.174 | Pyruvate kinase inhibitor | 0.174 0.098 DBMET00686 | DBMET00686 | |
| 0.056 | 0.178 | 0.092 | Potassium channel (Voltage-sensitive) activator | 0.092 0.066 DBMET00686 | DBMET00686 | |
| 0.059 | 0.185 | 0.121 | Nav1.6 sodium channel blocker | 0.121 0.094 DBMET00686 | DBMET00686 | |
| 0.035 | 0.162 | 0.061 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.061 0.042 DBMET00686 | DBMET00686 | |
| 0.041 | 0.171 | 0.072 | Glycine receptor antagonist | 0.072 0.07 DBMET00686 | DBMET00686 | |
| 0.004 | 0.138 | 0.03 | Estrogen receptor alpha agonist | 0.03 0.026 DBMET00686 | DBMET00686 | |
| 0.08 | 0.215 | 0.129 | Heat shock protein 90 antagonist | 0.129 0.099 DBMET00686 | DBMET00686 | |
| 0.135 | 0.281 | 0.246 | Alpha-glucosidase inhibitor | 0.246 0.19 DBMET00686 | DBMET00686 | |
| 0.053 | 0.2 | 0.123 | Protein kinase C gamma inhibitor | 0.123 0.05 DBMET00686 | DBMET00686 | |
| 0.008 | 0.156 | 0.043 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.043 0.019 DBMET00686 | DBMET00686 | |
| 0.05 | 0.198 | 0.104 | Glutamate receptor antagonist | 0.104 0.092 DBMET00686 | DBMET00686 | |
| 0.104 | 0.259 | 0.196 | Prostaglandin dehydrogenase inhibitor | 0.196 0.159 DBMET00686 | DBMET00686 | |
| 0.017 | 0.173 | 0.052 | Plasminogen activator inhibitor | 0.052 0.046 DBMET00686 | DBMET00686 | |
| 0.11 | 0.267 | 0.177 | Histone acetyltransferase inhibitor | 0.177 0.104 DBMET00686 | DBMET00686 | |
| 0.055 | 0.229 | 0.079 | Hematopoietic | 0.079 0.077 DBMET00686 | DBMET00686 | |
| 0.048 | 0.223 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.047 DBMET00686 | DBMET00686 | |
| 0.021 | 0.219 | 0.07 | Protein kinase C beta inhibitor | 0.07 0.048 DBMET00686 | DBMET00686 | |
| 0.017 | 0.253 | 0.055 | Protein kinase C eta inhibitor | 0.055 0.038 DBMET00686 | DBMET00686 | |
| 0.114 | 0.497 | 0.238 | MAP kinase kinase 6 inhibitor | 0.238 0.207 DBMET00686 | DBMET00686 | |
| 0.065 | 0.486 | 0.114 | Papain-like protease (SARS coronavirus) inhibitor | 0.114 0.099 DBMET00686 | DBMET00686 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |